View in EDS PDF Full Text

A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).

Saved in:
Bibliographic Details
Title: A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
Authors: Stebbing, J1, Harrison, M2, Glynne-Jones, R2, Bridgewater, J3, Propper, D4 d.j.propper@qmul.ac.uk
Source: British Journal of Cancer. 2/26/2008, Vol. 98 Issue 4, p716-719. 4p. 3 Charts.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 30000876
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Stebbing%2C+J%22">Stebbing, J</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Harrison%2C+M%22">Harrison, M</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Glynne-Jones%2C+R%22">Glynne-Jones, R</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Bridgewater%2C+J%22">Bridgewater, J</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Propper%2C+D%22">Propper, D</searchLink><relatesTo>4</relatesTo><i> d.j.propper@qmul.ac.uk</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 2/26/2008, Vol. 98 Issue 4, p716-719. 4p. 3 Charts.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=30000876
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/sj.bjc.6604232
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 716
    Titles:
      – TitleFull: A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stebbing, J
      – PersonEntity:
          Name:
            NameFull: Harrison, M
      – PersonEntity:
          Name:
            NameFull: Glynne-Jones, R
      – PersonEntity:
          Name:
            NameFull: Bridgewater, J
      – PersonEntity:
          Name:
            NameFull: Propper, D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 02
              Text: 2/26/2008
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-print
              Value: 00070920
          Numbering:
            – Type: volume
              Value: 98
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British Journal of Cancer
              Type: main
ResultId 1